Category Archives: Acetaminophen / Tylenol

Featured Stories

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Study Finds Higher Risk of ADHD Associated with Tylenol Use during Pregnancy

Higher Risk of ADHD with Tylenol Use during Pregnancy

A study published in the journal JAMA Pediatrics found that use of Tylenol (acetaminophen) during pregnancy was associated with a higher risk of behavioral problems such as attention-deficit/hyperactivity disorder (ADHD). The study was led by Evie Stergiakouli, a lecturer in … Continue reading

Posted in Acetaminophen / Tylenol, Pharmaceuticals | Tagged , , , , , , , , , , |

Dilantin Linked to Stevens-Johnson Syndrome, a Dangerous Skin Condition

Dilantin Linked to Stevens-Johnson Syndrome

Dilantin, the anti-epileptic drug that has been in use for decades is one of many drugs associated with the related skin conditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Though these conditions are rare, when they do occur they … Continue reading

Posted in Acetaminophen / Tylenol, Dilantin, Health Concerns, Lamictal, Pharmaceuticals, Zithromax | Tagged , , , , |

Two Life-Threatening Skin Reactions Have High Risk of Recurrence

People hospitalized for  (SJS) and toxic epidermal necrolysis (TEN), serious skin conditions that develop primarily as drug reactions, appear to have a high risk of recurrence, a new study reports. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening … Continue reading

Posted in Acetaminophen / Tylenol, Health Concerns, Pharmaceuticals |

Acetaminophen Doses Over 325mg Linked to Liver Damage

acetaminophen-doses-liver-damage-dangers

The U.S. Food and Drug Administration (FDA) has asked doctors to stop prescribing combination drugs that contain more than 325 milligrams of acetaminophen per dosage unit, citing the risk of liver damage. The FDA safety announcement issued on Tuesday said … Continue reading

Posted in Acetaminophen / Tylenol, Health Concerns, Pharmaceuticals |

Study: Do Not Mix Tylenol with Alcohol

mixing_tylenol_and_alchol_dangers

New research has found that mixing Tylenol (acetaminophen) and alcohol can increase risks for kidney disease. Even a very small amount of alcohol consumption when taking Tylenol can lead to serious increased risks. The study revealed that taking the recommended … Continue reading

Posted in Acetaminophen / Tylenol, Pharmaceuticals |

Too Much Acetaminophen Leads to Deadly Outcomes

acetaminophen_overuse_deadly_causes

Acetaminophen has been tied to over 1,500 deaths in the United States in the past 10 years. Acetaminophen is the active ingredient in the pain reliever and fever reducer, Tylenol. When overused, acetaminophen can lead to serious adverse effects, including … Continue reading

Posted in Acetaminophen / Tylenol, Pharmaceuticals |

Quality Control Issues Raised as J&J Issues Second Recall this Week

johnson-and-johnson_quality_control

In one week, health care giant, Johnson & Johnson, recalled two of its key products over quality issues. This, after working to reverse some bad press over scores of recalls, also due to quality issues, over the past couple of … Continue reading

Posted in Acetaminophen / Tylenol, Defective Medical Devices, Defective Products, Depuy, Pharmaceuticals, Product Recalls, Recalled Drugs, Recalled Medical Devices |

New Tylenol Cap Meant to Minimize Fatal Tylenol Overdoses

tylenol_caps_anti_overdose_cap

U.S. Tylenol bottles will soon bear a unique warning intended to alert people of the possibly deadly risks of taking too much of the drug’s main ingredient, acetaminophen. The red warnings will soon be found on the cap of every … Continue reading

Posted in Acetaminophen / Tylenol, Pharmaceuticals |

FDA Warns of Rare But Serious Acetaminophen Risk

fda_warns_of_acetaminophen_risk

On Thursday, the U.S. Food and Drug Administration (FDA) issued a warning to consumers of a link between the fever and pain reliever acetaminophen and rare but potentially fatal skin diseases. The FDA said it has identified evidence of a … Continue reading

Posted in Acetaminophen / Tylenol, Health Concerns, Pharmaceuticals |

Acetaminophen Use Caused Man’s Liver Failure, Death

A man’s paracetamol use led to acute liver failure and his death. Paracetamol is commonly known as acetaminophen, a painkiller and fever reducer also sold under the brand, Tylenol. Because of broad familiarity with acetaminophen, many people are not aware … Continue reading

Posted in Acetaminophen / Tylenol, Legal News, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.